Cynthia Imtiaz

Cynthia Imtiaz

Auto-generated profile, based on publicly available information

Cynthia Imtiaz

Department of Ocean System Engineering, Jeju National University, Jeju, Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2025 in Ultrasonography
Verified
Journal Article
Open access
PDF file
Dong-Guk PaengDong-Guk Paeng
Dong-Guk Paeng
CLCheong-Ah Lee
Cheong-Ah Lee
CICynthia Imtiaz
Cynthia Imtiaz
Doppler ultrasound is one of the oldest modalities for measuring and visualizing blood flow. This review paper explores the principles of Doppler ultrasound and blood flow imaging. Following a brief history of Doppler ultrasound, all Doppler modes, including B-Flow imaging, are discussed, with emphasis on spectral broadening and Doppler spectrum amplitude in relation to clinical implications. The paper also outlines sources of uncertainty in Doppler flow measurement. Emerging technologies in blood flow imaging are introduced, including microvascular flow imaging without contrast agents and four-dimensional vascular imaging from a two-dimensional transducer, which have been commercialized within the past decade, as well as row-column array transducer systems, high-frame-rate imaging, and photoacoustic imaging, which remain in preclinical and research stages.

6 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
CICynthia Imtiaz
Cynthia Imtiaz
CKChangsoo Kim
Changsoo Kim
Dong-Guk PaengDong-Guk Paeng
Dong-Guk Paeng
The blood–brain barrier (BBB) severely restricts the delivery of neuroprotective compounds to the brain, limiting therapeutic strategies for Parkinson’s disease (PD). Ginsenoside Rg3, a bioactive component of ginseng, has demonstrated neuroprotective potential, but its efficacy is constrained by poor BBB permeability. Here, we evaluated focused ultrasound (FUS)-mediated BBB opening (FUS BBBO) to enhance delivery of Rg3-loaded nanoparticles in a rotenone-induced mouse model of PD. Localized FUS sonication were applied to induce transient BBB disruption, followed by intraperitoneal administration of FITC-labeled Rg3 nanoparticles. In vivo fluorescence imaging confirmed a significant increase in brain accumulation of nanoparticles after FUS BBBO. While Rg3 nanoparticle treatment alone moderately increased ATP levels and Complex I activity, FUS alone produced a similar but slightly higher recovery. In contrast, the combination treatment with FUS-mediated BBBO achieved the most significant recovery (ATP: 0.27 ± 0.06, p < 0.01 vs. PD; Complex I: 1.98 ± 0.41, p < 0.05 vs. PD) and markedly improved motor performance compared with all other groups. These results demonstrate that FUS BBBO can effectively enhance targeted delivery of Rg3 nanoparticles to the brain, thereby restoring mitochondrial function and improving PD-associated motor deficits and locomotor performance. This noninvasive approach demonstrates that FUS BBBO can significantly enhance the therapeutic efficacy of Rg3 nanoparticles, offering a promising strategy for PD treatment.